CymaBay Therapeutics Announces Three Presentations at The Liver Meeting® 2022

October 3, 2022

https://www.globenewswire.com/news-release/2022/10/03/2526744/37067/en/CymaBay-Therapeutics-Announces-Three-Presentations-at-The-Liver-Meeting-2022.html

NEWARK, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced that three abstracts related to its seladelpar development program for the treatment of primary biliary cholangitis (PBC) will be presented at The Liver Meeting® of the American Association for the Study of Liver Diseases (AASLD), in Washington, DC (November 4th – 8th).

Read more at globenewswire.com

Related news for (CBAY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.